How to Increase the Diagnostic Value of Malignancy-related Ascites: Discriminative Ability of the Ascitic Tumour Markers
dc.contributor.author | Tuzun, Y. | |
dc.contributor.author | Yilmaz, M. | |
dc.contributor.author | Dursun, M. | |
dc.contributor.author | Canoruc, F. | |
dc.contributor.author | Celik, Y. | |
dc.contributor.author | Cil, T. | |
dc.contributor.author | Boyraz, T. | |
dc.date.accessioned | 2024-04-24T17:14:43Z | |
dc.date.available | 2024-04-24T17:14:43Z | |
dc.date.issued | 2009 | |
dc.department | Dicle Üniversitesi | en_US |
dc.description.abstract | Making a differential diagnosis between malignant and non-malignant ascites is an important clinical issue, but cytological examination has a relatively low diagnostic sensitivity. This study aimed to find a discriminative model that distinguished between malignancy-related and non-malignant ascites. The study included 107 patients: 50 with nonmalignant and 57 with malignant ascites. Ascites was analysed using a range of tumour markers and standard cytology. Standardized canonical discriminant function coefficients were used to distinguish between ascites types. The combination of carbohydrate antigen (CA) 15-3, carcinoembryonic antigen (CEA) and cytokeratin 19 fragments (CYFRA-21.1) discriminated between malignancy-related ascites and non-malignant ascites with an accuracy of 98.8% compared with an accuracy of 77.8% for cytological examination. In conclusion, the use of a discriminant function constructed from a combination of CA15-3, CEA and CYFRA-21.1 could distinguish malignant from non-malignant ascites with greater accuracy than cytological examination. Further studies in larger population groups are warranted. | en_US |
dc.identifier.doi | 10.1177/147323000903700110 | |
dc.identifier.endpage | 95 | en_US |
dc.identifier.issn | 0300-0605 | |
dc.identifier.issue | 1 | en_US |
dc.identifier.pmid | 19215677 | |
dc.identifier.scopus | 2-s2.0-64149098878 | |
dc.identifier.scopusquality | Q2 | |
dc.identifier.startpage | 87 | en_US |
dc.identifier.uri | https://doi.org/10.1177/147323000903700110 | |
dc.identifier.uri | https://hdl.handle.net/11468/18156 | |
dc.identifier.volume | 37 | en_US |
dc.identifier.wos | WOS:000264163500010 | |
dc.identifier.wosquality | Q4 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | en_US |
dc.publisher | Field House Publishing Llp | en_US |
dc.relation.ispartof | Journal of International Medical Research | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Cancer | en_US |
dc.subject | Cancer Patients | en_US |
dc.subject | Diagnosis | en_US |
dc.subject | Rumour Markers | en_US |
dc.subject | Ascites | en_US |
dc.subject | Discriminant Function | en_US |
dc.title | How to Increase the Diagnostic Value of Malignancy-related Ascites: Discriminative Ability of the Ascitic Tumour Markers | en_US |
dc.title | How to Increase the Diagnostic Value of Malignancy-related Ascites: Discriminative Ability of the Ascitic Tumour Markers | |
dc.type | Article | en_US |